Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant in hospitalized COVID-19 patients
NCT04470622Phase 2Terminated
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in coronavirus disease 2019 (COVID-19), sponsored by Heron Therapeutics, Inc.. Started Jul 2020; status: terminated.
02
Drugs
aprepitant
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04470622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470622.